Migraine Excellence Hub

In interim INFUSE data, ≥50% of adults with prior anti-CGRP preventive failure reported cognitive symptom improvement after eptinezumab.

In interim INFUSE data, ≥50% of adults with prior anti-CGRP preventive failure reported cognitive symptom improvement after eptinezumab.

In interim INFUSE data, ≥50% of adults with prior anti-CGRP preventive failure reported cognitive symptom improvement after eptinezumab.

In interim INFUSE data, ≥50% of adults with prior anti-CGRP preventive failure reported cognitive symptom improvement after eptinezumab.

In interim INFUSE data, ≥50% of adults with prior anti-CGRP preventive failure reported cognitive symptom improvement after eptinezumab.

This AAEM26 session examined a multihospital program, highlighting teletriage, virtual ED care, and more.

This AAEM26 session examined a multihospital program, highlighting teletriage, virtual ED care, and more.

This AAEM26 session examined a multihospital program, highlighting teletriage, virtual ED care, and more.

This AAEM26 session examined a multihospital program, highlighting teletriage, virtual ED care, and more.

This AAEM26 session reviewed recent evidence challenging traditional approaches to common orthopedic injuries.